William Plovanic
Stock Analyst at Canaccord Genuity
(2.12)
# 2,977
Out of 5,241 analysts
191
Total ratings
35.67%
Success rate
-3.56%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HTFL HeartFlow | Maintains: Buy | $43 → $37 | $28.32 | +30.67% | 6 | May 15, 2026 | |
| CBLL CeriBell | Maintains: Buy | $28 → $25 | $16.35 | +52.91% | 6 | May 12, 2026 | |
| PODD Insulet | Maintains: Buy | $435 → $249 | $147.46 | +68.86% | 9 | May 7, 2026 | |
| TMDX TransMedics Group | Maintains: Buy | $152 → $124 | $63.20 | +96.20% | 10 | May 6, 2026 | |
| ATRC AtriCure | Maintains: Buy | $53 → $55 | $28.12 | +95.59% | 14 | May 6, 2026 | |
| IRTC iRhythm Holdings | Maintains: Buy | $198 → $180 | $114.00 | +57.89% | 15 | May 1, 2026 | |
| DXCM DexCom | Maintains: Buy | $95 → $100 | $61.63 | +62.26% | 11 | May 1, 2026 | |
| EW Edwards Lifesciences | Maintains: Hold | $87 → $85 | $81.38 | +4.45% | 31 | Apr 24, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $109 → $71 | $52.68 | +34.78% | 16 | Apr 23, 2026 | |
| CVRX CVRx, Inc. | Maintains: Buy | $10 | $5.99 | +66.94% | 11 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $3 | $1.28 | +134.38% | 5 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 | $2.68 | +161.19% | 7 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $48 | $22.77 | +110.80% | 5 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $35 | $12.82 | +173.01% | 7 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $10.77 | +67.13% | 8 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $76.64 | +17.43% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $83.70 | +20.67% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $10.58 | +41.78% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $322.32 | -11.89% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $7.66 | +226.37% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.27 | +844.88% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $61.31 | +14.17% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $32.07 | +49.67% | 5 | Aug 3, 2023 |
HeartFlow
May 15, 2026
Maintains: Buy
Price Target: $43 → $37
Current: $28.32
Upside: +30.67%
CeriBell
May 12, 2026
Maintains: Buy
Price Target: $28 → $25
Current: $16.35
Upside: +52.91%
Insulet
May 7, 2026
Maintains: Buy
Price Target: $435 → $249
Current: $147.46
Upside: +68.86%
TransMedics Group
May 6, 2026
Maintains: Buy
Price Target: $152 → $124
Current: $63.20
Upside: +96.20%
AtriCure
May 6, 2026
Maintains: Buy
Price Target: $53 → $55
Current: $28.12
Upside: +95.59%
iRhythm Holdings
May 1, 2026
Maintains: Buy
Price Target: $198 → $180
Current: $114.00
Upside: +57.89%
DexCom
May 1, 2026
Maintains: Buy
Price Target: $95 → $100
Current: $61.63
Upside: +62.26%
Edwards Lifesciences
Apr 24, 2026
Maintains: Hold
Price Target: $87 → $85
Current: $81.38
Upside: +4.45%
Boston Scientific
Apr 23, 2026
Maintains: Buy
Price Target: $109 → $71
Current: $52.68
Upside: +34.78%
CVRx, Inc.
Apr 14, 2026
Maintains: Buy
Price Target: $10
Current: $5.99
Upside: +66.94%
Mar 19, 2026
Maintains: Buy
Price Target: $7 → $3
Current: $1.28
Upside: +134.38%
Mar 9, 2026
Maintains: Buy
Price Target: $7
Current: $2.68
Upside: +161.19%
Feb 13, 2026
Maintains: Buy
Price Target: $51 → $48
Current: $22.77
Upside: +110.80%
Dec 17, 2025
Maintains: Buy
Price Target: $24 → $35
Current: $12.82
Upside: +173.01%
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $10.77
Upside: +67.13%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $76.64
Upside: +17.43%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $83.70
Upside: +20.67%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $10.58
Upside: +41.78%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $322.32
Upside: -11.89%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $7.66
Upside: +226.37%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.27
Upside: +844.88%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $61.31
Upside: +14.17%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $32.07
Upside: +49.67%